Profit & Loss: America on Dialysis
Special Report
Special Report
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone’s journey is the same.
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?
Minority patients are diagnosed later, stay on dialysis longer, and are added to transplant lists less quickly. Why?
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?
Demand for healthy kidneys has long outstripped supply. But better testing and treatment is expanding the donor pool.
December 17, 2020 — Carrie Arnold and Larry C. Price
Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing.
6 hours ago — Carrie Arnold and Larry C. Price
Kidney disease affects millions of Americans, but corporate capture of dialysis, along with disparities in treatment and transplant access, mean that not everyone’s journey is the same…
December 14, 2020 — Jeffery DelViscio and Carrie Arnold
Source link
